Milestone Pharmaceuticals Ownership | Who Owns Milestone Pharmaceuticals?

Milestone Pharmaceuticals Ownership Summary

Milestone Pharmaceuticals is owned by 37.09% institutional investors, 0.66% insiders, and 62.25% retail investors. Blackrock is the largest institutional shareholder, holding 9.91% of MIST shares. Biotech Growth Ord is the top mutual fund, with 1.81% of its assets in Milestone Pharmaceuticals shares.

MIST Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Milestone Pharmaceuticals	37.09%	0.66%	62.25%
Sector	Healthcare Stocks	57.39%	9.93%	32.68%
Industry	Biotech Stocks	68.48%	9.65%	21.87%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock	4.97M	9.91%	$6.56M
Blackrock funding, inc. /de	4.05M	6.12%	$9.56M
Millennium management	2.70M	4.08%	$6.38M
Alta fundamental advisers	2.66M	4.02%	$6.27M
Rtw investments, lp	2.51M	3.79%	$5.91M
Orbimed advisors	2.00M	3.02%	$4.72M
Nantahala capital management	1.45M	2.18%	$3.41M
Bleichroeder lp	1.33M	2.00%	$3.13M
Bml capital management	1.14M	1.72%	$2.68M
Morgan stanley	828.65K	1.65%	$1.09M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Lion point capital, lp	1.03M	12.68%	$2.42M
Alta fundamental advisers	2.66M	1.88%	$6.27M
Bml capital management	1.14M	1.67%	$2.68M
Stonepine capital management	500.00K	0.95%	$1.18M
Bleichroeder lp	1.33M	0.79%	$3.13M
Ikarian capital	466.03K	0.15%	$1.10M
Nantahala capital management	1.45M	0.15%	$3.41M
Orbimed advisors	2.00M	0.10%	$4.72M
Rtw investments, lp	2.51M	0.09%	$5.91M
Boxer capital	309.01K	0.02%	$407.89K

Top Buyers

Holder	Shares	% Assets	Change
Toronto dominion bank	750.00K	0.00%	750.00K
Ubs group	89.51K	-	89.51K
Virtu financial	71.95K	0.01%	71.95K
Group one trading	52.64K	0.00%	52.64K
Xtx topco	34.05K	0.01%	34.05K

Top Sellers

Holder	Shares	% Assets	Change
Blackrock funding, inc. /de	4.05M	0.00%	-920.66K
Rtw investments, lp	2.51M	0.09%	-750.00K
Velan capital investment management lp	-	-	-650.00K
Lion point capital, lp	1.03M	12.68%	-628.35K
Monashee investment management	-	-	-500.00K

New Positions

Holder	Shares	% Assets	Change	Value
Toronto dominion bank	750.00K	0.00%	750.00K	$1.77M
Ubs group	89.51K	-	89.51K	$211.23K
Virtu financial	71.95K	0.01%	71.95K	$170.00K
Group one trading	52.64K	0.00%	52.64K	$124.22M
Xtx topco	34.05K	0.01%	34.05K	$80.37K

Sold Out

Holder	Change
Qube research	-194.00
Ica group wealth management	-200.00
Royal bank of canada	-800.00
Citadel advisors	-3.50K
Engineers gate manager lp	-11.07K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2024	49	16.67%	24,552,980	-14.38%	37	1.98%	24	71.43%	14	75.00%
Sep 30, 2024	41	-	28,647,040	-5.08%	43	1.20%	13	-	8	33.33%
Jun 30, 2024	41	-6.82%	30,178,631	-3.74%	60	1.13%	13	-48.00%	6	20.00%
Mar 31, 2024	44	4.76%	31,351,699	76.28%	72	4.26%	25	56.25%	5	-50.00%
Dec 31, 2023	42	5.00%	17,784,737	-8.16%	41	2.03%	16	45.45%	10	-28.57%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Biotech Growth Ord	963.40K	1.81%	-
Simplify Propel Opportunities ETF	200.00K	0.37%	200.00K
LUNIS Biotech Growth Opp Fd I a	26.90K	0.05%	-
WEALTHGATE Biotech Fund Inst	26.90K	0.05%	26.90K
Fidelity Nasdaq Composite Index	19.87K	0.04%	-
SPDR® S&P® International Small Cap ETF	18.54K	0.03%	-
Dimensional Global Core Equity USD Acc	5.87K	0.01%	-
Dimensional Global Small Coms USD Acc	5.02K	0.01%	-
Dimensional World Equity GBP Acc	3.65K	0.01%	-
Dimensional Gl Cor Eq LC ESG Sc USD A	2.70K	0.01%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Dec 01, 2022	Bharucha David	Chief Medical Officer	Buy	$14.58K
Dec 05, 2022	Bharucha David	Chief Medical Officer	Buy	$32.83K
Oct 19, 2022	Wills Robert James	-	Buy	$73.95K
Oct 20, 2022	Pasternak Richard C	-	Buy	$52.00K
Oct 20, 2022	Liebert Debra K.	-	Buy	$52.90K

Insider Transactions Trends

Date	Buy	Sell
2025 Q1	-	-
2024 Q3	-	-
2023 Q2	-	-
2023 Q1	-	-
2022 Q4	7	-

MIST Ownership FAQ

Who Owns Milestone Pharmaceuticals?

Milestone Pharmaceuticals shareholders are primarily institutional investors at 37.09%, followed by 0.66% insiders and 62.25% retail investors. The average institutional ownership in Milestone Pharmaceuticals's industry, Biotech Stocks , is 68.48%, which Milestone Pharmaceuticals falls below.

Who owns the most shares of Milestone Pharmaceuticals?

Milestone Pharmaceuticals’s largest shareholders are Blackrock (4.97M shares, 9.91%), Blackrock funding, inc. /de (4.05M shares, 6.12%), and Millennium management (2.7M shares, 4.08%). Together, they hold 20.12% of Milestone Pharmaceuticals’s total shares outstanding.

Does Blackrock own Milestone Pharmaceuticals?

Yes, BlackRock owns 9.91% of Milestone Pharmaceuticals, totaling 4.97M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 6.56M$. In the last quarter, BlackRock decreased its holdings by 0 shares, a 0% change.

Who is Milestone Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Lion point capital, lp is Milestone Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 12.68% of its assets in 1.03M Milestone Pharmaceuticals shares, valued at 2.42M$.

Who is the top mutual fund holder of Milestone Pharmaceuticals shares?

Biotech Growth Ord is the top mutual fund holder of Milestone Pharmaceuticals shares, with 1.81% of its total shares outstanding invested in 963.4K Milestone Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools